Undesirable phenotypes may include, for example, poor growth, reduced levels of nutrients, increased levels of natural toxicants, etc. To address unrecognized toxic substances that may unexpectedly appear in transgenic plants or to evaluate plants that normally contain many toxic substances at very low levels, toxicological evaluation of the edible plant tissue may be more appropriate than using chemical identification and quantification procedures. Division of Food Chemistry and Technology and Division of Contaminants Chemistry . Dated November 1, 1991. Monsanto should not have to vouchsafe the safety of biotech food.
Out interest is in selling as much of it as possible.
Phil Angell , Director of Corporate Communications, Monsanto. Under this authority, foods made up of proteins, fats and carbohydrates with a history of safe use in food can be sold once companies are satisfied the new product is safe without first getting FDA permission. These concerns were expressed in light of a policy proposal by the Food and Drug Administration. In fact, the FDA implemented policies which conflict directly with the recomendations of these government scientists. Naturally enough, other scientists, being free to take a broader look at genetic engineering, have also raised concerns .